Entries by CURC

Dr. Shore Discusses Hormonal Therapy In Prostate Cancer For Learning Clinicians

/0 Comments/in /by

Dr. Shore, an expert in urologic oncology, discusses hormonal therapy in prostate cancer. He leads an educational discussion and course on prostate cancer for learning clinicians. The activity has been designed to meet the educational needs of oncologists, urologists, advanced practice clinicians, and other professionals involved in the management of patients with prostate cancer.  For clinicians to […]

Dr. Shore & Colleagues Host A 4-Part Interactive Webinar Series For Learning Clinicians

/0 Comments/in /by

Key Issues For The Advanced Bladder Cancer Clinic: Incorporating Immunotherapy Into Your Community-Based Urology Practice Join Dr. Neal Shore and his esteemed colleagues for this four-part webinar series focused on the implementation of IO, as well as other recently approved advanced bladder cancer therapies. This series was designed for all clinicians interested in bladder cancer […]

Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

/0 Comments/in /by

Prof Stephen A Boorjian, MD, Mehrdad Alemozaffar, MD, Prof Badrinath R Konety, MD, Neal D Shore, MD, Prof Leonard G Gomella, MD, Prof Ashish M Kamat, MD, et al. Background: BCG is the most effective therapy for high-risk non-muscle-invasive bladder cancer. Nadofaragene firadenovec (also known as rAd-IFNa/Syn3) is a replication-deficient recombinant adenovirus that delivers human interferon […]